Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
Clinical trial NCT00086775 · COMPLETED
Trial details
- NCT number
- NCT00086775
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2005-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.